Anika Reports First Quarter 2017 Financial Results
MONOVISC Revenue Increases 24% Year-over-Year Total Revenue Grows 5% Year-over-Year Commercially Launches ORTHOVISC-T in Europe BEDFORD, Mass., May 03, 2017 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ:ANIK), a global, integrated orthopedic …